Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4

Susumu Matsuda, Seiji Umemoto, Koichi Yoshimura, Shinichi Itoh, Tomoaki Murata, Tohru Fukai, Masunori Matsuzaki

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Aim: Angiotensin Ⅱ (AngⅡ) produces reactive oxygen species (ROS), thus contributing to the development of cardiac hypertrophy and subsequent heart failure, and stimulates the expression of monocyte chemoattractant protein-1 (MCP-1). In addition, Toll-like receptor 4 (TLR4) is involved in the upregulation of MCP-1. In order to clarify whether TLR4 is involved in the onset of cardiac dysfunction caused by AngⅡ stimulation, we investigated the effects of TLR4 on oxidative stress, the MCP-1 expression and cardiac dysfunction in mice with AngⅡ-induced hypertension. Methods: TLR4-deficient (Tlr4lps-d) and wild-type (WT) mice were randomized into groups treated with AngⅡ, norepinephrine (NE) or a subdepressor dose of the AngⅡ receptor blocker irbesartan (IRB) and AngⅡ for two weeks. Results: AngⅡ and NE similarly increased systolic blood pressure in all drug-treated groups compared to that observed in the control group among both WT and Tlr4lps-d mice (p<0.05). In the WT mice, AngⅡ induced cardiac hypertrophy as well as vascular remodeling and perivascular fibrosis of the intramyocardial arteries and monocyte/macrophage infiltration in the heart (p<0.05). Furthermore, AngⅡ treatment decreased the left ventricular diastolic function and resulted in a greater left ventricular end-systolic dimension (p<0.05) in addition to producing a five-fold increase in the NADPH oxidase activity, ROS content and MCP-1 expression (p<0.05). In contrast, the Tlr4lps-d mice showed little effects of AngⅡ on these indices. In the WT mice, IRB treatment reversed these changes compared to that seen in the mice treated with AngⅡ alone. NE produced little effect on any of the indices in either the WT or Tlr4lps-d mice. Conclusions: TLR4 may be involved in the processes underlying the increased oxidative stress, selectively activated MCP-1 expression and cardiac hypertrophy and dysfunction seen in cases of AngⅡ- induced hypertension.

Original languageEnglish (US)
Pages (from-to)833-844
Number of pages12
JournalJournal of Atherosclerosis and Thrombosis
Volume22
Issue number8
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Toll-Like Receptor 4
Chemokine CCL2
Angiotensins
Cardiomegaly
Angiotensin II
irbesartan
Norepinephrine
Oxidative stress
Reactive Oxygen Species
Oxidative Stress
Blood Pressure
Hypertension
Macrophages
NADPH Oxidase
Angiotensin Receptor Antagonists
Blood pressure
Left Ventricular Function
Infiltration
Monocytes
Fibrosis

Keywords

  • Angiotensin II
  • Cardiac hypertrophy
  • Hypertension
  • Monocyte chemoattractant protein-1
  • Mouse
  • Toll-like receptor 4

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Biochemistry, medical

Cite this

Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4. / Matsuda, Susumu; Umemoto, Seiji; Yoshimura, Koichi; Itoh, Shinichi; Murata, Tomoaki; Fukai, Tohru; Matsuzaki, Masunori.

In: Journal of Atherosclerosis and Thrombosis, Vol. 22, No. 8, 01.01.2015, p. 833-844.

Research output: Contribution to journalArticle

Matsuda, Susumu ; Umemoto, Seiji ; Yoshimura, Koichi ; Itoh, Shinichi ; Murata, Tomoaki ; Fukai, Tohru ; Matsuzaki, Masunori. / Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4. In: Journal of Atherosclerosis and Thrombosis. 2015 ; Vol. 22, No. 8. pp. 833-844.
@article{87c2f193d2d34e54b482597ab928dcca,
title = "Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4",
abstract = "Aim: Angiotensin Ⅱ (AngⅡ) produces reactive oxygen species (ROS), thus contributing to the development of cardiac hypertrophy and subsequent heart failure, and stimulates the expression of monocyte chemoattractant protein-1 (MCP-1). In addition, Toll-like receptor 4 (TLR4) is involved in the upregulation of MCP-1. In order to clarify whether TLR4 is involved in the onset of cardiac dysfunction caused by AngⅡ stimulation, we investigated the effects of TLR4 on oxidative stress, the MCP-1 expression and cardiac dysfunction in mice with AngⅡ-induced hypertension. Methods: TLR4-deficient (Tlr4lps-d) and wild-type (WT) mice were randomized into groups treated with AngⅡ, norepinephrine (NE) or a subdepressor dose of the AngⅡ receptor blocker irbesartan (IRB) and AngⅡ for two weeks. Results: AngⅡ and NE similarly increased systolic blood pressure in all drug-treated groups compared to that observed in the control group among both WT and Tlr4lps-d mice (p<0.05). In the WT mice, AngⅡ induced cardiac hypertrophy as well as vascular remodeling and perivascular fibrosis of the intramyocardial arteries and monocyte/macrophage infiltration in the heart (p<0.05). Furthermore, AngⅡ treatment decreased the left ventricular diastolic function and resulted in a greater left ventricular end-systolic dimension (p<0.05) in addition to producing a five-fold increase in the NADPH oxidase activity, ROS content and MCP-1 expression (p<0.05). In contrast, the Tlr4lps-d mice showed little effects of AngⅡ on these indices. In the WT mice, IRB treatment reversed these changes compared to that seen in the mice treated with AngⅡ alone. NE produced little effect on any of the indices in either the WT or Tlr4lps-d mice. Conclusions: TLR4 may be involved in the processes underlying the increased oxidative stress, selectively activated MCP-1 expression and cardiac hypertrophy and dysfunction seen in cases of AngⅡ- induced hypertension.",
keywords = "Angiotensin II, Cardiac hypertrophy, Hypertension, Monocyte chemoattractant protein-1, Mouse, Toll-like receptor 4",
author = "Susumu Matsuda and Seiji Umemoto and Koichi Yoshimura and Shinichi Itoh and Tomoaki Murata and Tohru Fukai and Masunori Matsuzaki",
year = "2015",
month = "1",
day = "1",
doi = "10.5551/jat.27292",
language = "English (US)",
volume = "22",
pages = "833--844",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "8",

}

TY - JOUR

T1 - Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4

AU - Matsuda, Susumu

AU - Umemoto, Seiji

AU - Yoshimura, Koichi

AU - Itoh, Shinichi

AU - Murata, Tomoaki

AU - Fukai, Tohru

AU - Matsuzaki, Masunori

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Aim: Angiotensin Ⅱ (AngⅡ) produces reactive oxygen species (ROS), thus contributing to the development of cardiac hypertrophy and subsequent heart failure, and stimulates the expression of monocyte chemoattractant protein-1 (MCP-1). In addition, Toll-like receptor 4 (TLR4) is involved in the upregulation of MCP-1. In order to clarify whether TLR4 is involved in the onset of cardiac dysfunction caused by AngⅡ stimulation, we investigated the effects of TLR4 on oxidative stress, the MCP-1 expression and cardiac dysfunction in mice with AngⅡ-induced hypertension. Methods: TLR4-deficient (Tlr4lps-d) and wild-type (WT) mice were randomized into groups treated with AngⅡ, norepinephrine (NE) or a subdepressor dose of the AngⅡ receptor blocker irbesartan (IRB) and AngⅡ for two weeks. Results: AngⅡ and NE similarly increased systolic blood pressure in all drug-treated groups compared to that observed in the control group among both WT and Tlr4lps-d mice (p<0.05). In the WT mice, AngⅡ induced cardiac hypertrophy as well as vascular remodeling and perivascular fibrosis of the intramyocardial arteries and monocyte/macrophage infiltration in the heart (p<0.05). Furthermore, AngⅡ treatment decreased the left ventricular diastolic function and resulted in a greater left ventricular end-systolic dimension (p<0.05) in addition to producing a five-fold increase in the NADPH oxidase activity, ROS content and MCP-1 expression (p<0.05). In contrast, the Tlr4lps-d mice showed little effects of AngⅡ on these indices. In the WT mice, IRB treatment reversed these changes compared to that seen in the mice treated with AngⅡ alone. NE produced little effect on any of the indices in either the WT or Tlr4lps-d mice. Conclusions: TLR4 may be involved in the processes underlying the increased oxidative stress, selectively activated MCP-1 expression and cardiac hypertrophy and dysfunction seen in cases of AngⅡ- induced hypertension.

AB - Aim: Angiotensin Ⅱ (AngⅡ) produces reactive oxygen species (ROS), thus contributing to the development of cardiac hypertrophy and subsequent heart failure, and stimulates the expression of monocyte chemoattractant protein-1 (MCP-1). In addition, Toll-like receptor 4 (TLR4) is involved in the upregulation of MCP-1. In order to clarify whether TLR4 is involved in the onset of cardiac dysfunction caused by AngⅡ stimulation, we investigated the effects of TLR4 on oxidative stress, the MCP-1 expression and cardiac dysfunction in mice with AngⅡ-induced hypertension. Methods: TLR4-deficient (Tlr4lps-d) and wild-type (WT) mice were randomized into groups treated with AngⅡ, norepinephrine (NE) or a subdepressor dose of the AngⅡ receptor blocker irbesartan (IRB) and AngⅡ for two weeks. Results: AngⅡ and NE similarly increased systolic blood pressure in all drug-treated groups compared to that observed in the control group among both WT and Tlr4lps-d mice (p<0.05). In the WT mice, AngⅡ induced cardiac hypertrophy as well as vascular remodeling and perivascular fibrosis of the intramyocardial arteries and monocyte/macrophage infiltration in the heart (p<0.05). Furthermore, AngⅡ treatment decreased the left ventricular diastolic function and resulted in a greater left ventricular end-systolic dimension (p<0.05) in addition to producing a five-fold increase in the NADPH oxidase activity, ROS content and MCP-1 expression (p<0.05). In contrast, the Tlr4lps-d mice showed little effects of AngⅡ on these indices. In the WT mice, IRB treatment reversed these changes compared to that seen in the mice treated with AngⅡ alone. NE produced little effect on any of the indices in either the WT or Tlr4lps-d mice. Conclusions: TLR4 may be involved in the processes underlying the increased oxidative stress, selectively activated MCP-1 expression and cardiac hypertrophy and dysfunction seen in cases of AngⅡ- induced hypertension.

KW - Angiotensin II

KW - Cardiac hypertrophy

KW - Hypertension

KW - Monocyte chemoattractant protein-1

KW - Mouse

KW - Toll-like receptor 4

UR - http://www.scopus.com/inward/record.url?scp=84940387844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940387844&partnerID=8YFLogxK

U2 - 10.5551/jat.27292

DO - 10.5551/jat.27292

M3 - Article

C2 - 25752363

AN - SCOPUS:84940387844

VL - 22

SP - 833

EP - 844

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 8

ER -